Platinum Industries Ltd (PLATIND)
🎯 Key Takeaways
- Platinum Industries Ltd is in a strategic growth phase, actively scaling capacity in high-margin CPVC and lead-based chemical segments through geographic expansion into Egypt and Palghar. Management is targeting 40% revenue growth in FY27 and 35% CAGR through FY29, supported by R&D and operational investments.
- Revenue declined 17.5% QoQ to ₹109 in Q1FY27.
- ⚠️ Execution delays in Egypt and Palghar projects due to regulatory hurdles could postpone revenue contribution and margin improvement targets.
- Market Cap
- ₹1,137
- P/E Ratio
- 22.6
- P/B Ratio
- 2.57
- ROE
- 11.4%
- ROCE
- 14.5%
- Debt/Equity
- 0.02
- Promoter
- 70.0%
📖 The Story
Platinum Industries Ltd is in a strategic growth phase, actively scaling capacity in high-margin CPVC and lead-based chemical segments through geographic expansion into Egypt and Palghar. Management is targeting 40% revenue growth in FY27 and 35% CAGR through FY29, supported by R&D and operational investments. However, near-term financial performance shows margin pressure and revenue volatility, with PAT margin at 10.2% in Q1 FY27 and revenue declining 5.6% YoY in Q1 FY27, indicating execution risks in converting capacity into profitable growth.
📰 What's Happening
In Q1 FY27, the company reported consolidated revenue of ₹1,089.4 million and PAT of ₹111.3 million, with PAT margin expanding to 10.2% from standalone 8.7%. Management highlighted progress on two key capacity expansions — ₹677.21 million allocated to Egypt and ₹712.61 million to Palghar — funded by IPO proceeds. The Monitoring Agency Report confirms utilization of ₹1,507.85 million of ₹2,118.29 million raised, with delays in regulatory approvals affecting timelines. CAPEX of ₹68 crores was deployed in Egypt, and management targets CPVC margin improvement to 20-21% by Q4 FY27 and Oleo segment sales of ₹55-60 crores by year-end.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 98 | 105 | 132 | 109 |
| Operating Profit | 12 | 14 | 14 | 12 |
| OPM % | 12.4% | 13.5% | 10.4% | 10.7% |
| Net Profit | 11 | 12 | 15 | 11 |
| EPS | ₹2.11 | ₹2.29 | ₹2.75 | ₹2.03 |
Revenue trends show volatility, with Q1 FY27 revenue at ₹109 crores, down from ₹132 crores in Q4 FY26, reflecting macro and product mix headwinds. Despite this, OPM held steady at 10.7%, and PAT remained flat at ₹11 crores, suggesting cost discipline. However, the sequential decline in revenue and margin pressure from raw material costs and lower-margin product mix have offset gains from scale. The company’s growth narrative hinges on future capacity utilization in Egypt and Palghar, but current quarter performance indicates a ramp-up phase with delayed monetization.
🔮 Management Outlook & What's Next
Management has provided forward-looking targets: 40% revenue growth in FY27 and 35% CAGR through FY29, driven by geographic diversification and CPVC additive expansion. They expect CPVC margin to reach 20-21% by Q4 FY27 and Oleo segment sales to reach ₹55-60 crores by year-end. CAPEX deployment is on track, with ₹68 crores invested in Egypt and remaining IPO proceeds to be utilized by FY27 per prospectus. Management emphasizes sustainable innovation and R&D as enablers of long-term margin accretion, though near-term execution remains contingent on regulatory clearances.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 55 | 55 | 55 | 55 |
| Reserves | 329 | 308 | 388 | 354 |
| Borrowings | 9 | 14 | 10 | 27 |
| Total Liabilities | 468 | 427 | 549 | 515 |
| Fixed Assets | 61 | 70 | 109 | 102 |
| Investments | 42 | 16 | 48 | 29 |
| Total Assets | 468 | 427 | 549 | 515 |
The balance sheet reflects a strong equity base of ₹55 crores and growing reserves, with borrowings remaining minimal at ₹10 crores as of March 2026. Total assets have risen to ₹549 crores from ₹468 crores in March 2025, indicating capital deployment into expansion assets. IPO proceeds are being utilized as planned, with ₹1,507.85 million deployed and the remainder to be used in FY27. The low D/E of 0.02 underscores a conservative capital structure, supporting financial flexibility during the investment phase.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | -8 |
| Investing | -159 |
| Financing | +1 |
| Net Cash Flow | -166 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 71.0% | 70.0% | 70.0% | 70.0% |
| FII | 0.6% | 0.6% | 0.6% | 0.3% |
| DII | 3.0% | 3.0% | 3.6% | 3.7% |
| Public | 18.9% | 19.9% | 19.4% | 19.5% |
| # Shareholders | 43,717 | 43,674 | 42,792 | 41,218 |
Promoter holding remains stable at 70.03% over the last four quarters, indicating confidence in long-term prospects. FII ownership has modestly increased from 0.59% in Q4 FY26 to 0.35% in Q1 FY27, while DII rose from 2.95% to 3.68%, suggesting growing institutional interest. The number of public shareholders has expanded to 41,218 in Q1 FY27 from 43,674 in Q3 FY26, reflecting broader retail participation. No significant dilution or pledging signals are evident.
⚖️ Peer Comparison — Chemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.53 L Cr | 57.6 | 33.4% | — | 0.01 |
| SRF | 73,810 | 34.1 | 15.6% | — | 0.36 |
| LINDEINDIA | 52,814 | 96.7 | 17.5% | — | 0.00 |
| FLUOROCHEM | 48,774 | 79.7 | 9.6% | — | 0.34 |
| NAVINFLUOR | 43,256 | 54.7 | 22.2% | — | 0.31 |
| GODREJIND | 36,153 | 30.8 | 9.2% | — | 4.57 |
| HSCL | 33,807 | 42.0 | 20.7% | — | 0.16 |
| AETHER | 23,029 | 97.7 | 13.8% | — | 0.08 |
| DEEPAKNTR | 21,155 | 27.0 | 15.3% | — | 0.26 |
| CASTROLIND | 19,891 | 18.7 | 76.2% | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Execution delays in Egypt and Palghar projects due to regulatory hurdles could postpone revenue contribution and margin improvement targets. 2. Persistent raw material cost inflation and product mix shifts are pressuring near-term margins despite operational scale. 3. The qualified audit opinion over a ₹98.19 crore insurance claim introduces uncertainty in subsidiary valuation and cash flow expectations. 4. High CAPEX outflows without immediate revenue ramp-up may strain liquidity if project timelines slip further.
📋 Recent Filings
- 🔴 Announcement2026-09-29Platinum Industries announced that its subsidiary Rivadu Lifesciences entered an exclusive sale-purchase agreement with South Korea's Caregen for the …
- Announcement2026-09-25Platinum Industries Ltd announced that its trading window will close on October 1, 2026, and remain shut for 48 hours after the board approves unaudit…
- Announcement2026-09-24Platinum Industries Ltd announced a plant visit for investors and analysts at its Palghar, Maharashtra facility on Tuesday, 29 September 2026, as per …
- 🟡 Board Meeting2026-09-24Platinum Industries held its 6th AGM on 24 September 2026 via video conference, approving audited standalone and consolidated financial statements for…
- 🔴 annual report2026-09-03Platinum Industries Limited disclosed that shareholders without registered email addresses can access the Annual Report FY 2025-26 and Notice of 6th A…
- 🟡 Board Meeting2026-09-02Platinum Industries Limited announced its 6th AGM on 24 September 2026, seeking shareholder approval for key resolutions including adoption of FY 2025…
- 🔴 annual report2026-09-02Platinum Industries Ltd (PLATIND) reported a 14.8% YoY revenue increase to ₹4,504.40 million in FY26, driven by PVC stabilizers and CPVC additives, wi…
- Announcement2026-08-13Platinum Industries reported Q1 FY27 revenue of INR 108.9 crores, down from INR 115.4 crores YoY, with PAT at INR 11.13 crores. Management highlighted…
- 🔴 Financial Results2026-08-11Platinum Industries Limited reported Q1 FY27 consolidated revenue of ₹1,089.4 million and PAT of ₹111.3 million, with PAT margin at 10.2%. The company…
- 🔴 offer document2026-08-11Platinum Industries Limited disclosed its Monitoring Agency Report for the quarter ended June 30, 2026, confirming utilization of IPO proceeds for spe…
🧠 Analyst's Read
Platinum Industries is executing a capital-intensive expansion strategy with long-term growth ambitions, but near-term financials reflect the challenges of scaling in a capital- and input-intensive chemical business. Investors should monitor regulatory progress in Egypt and Palghar, margin trajectory in CPVC, and the resolution of the insurance claim as key near-term catalysts.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-29.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when PLATIND files new disclosures
Track PLATIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track PLATIND — FreeFree account · 2 AI queries/day